IN-NGF has been extensively studied in preclinical models of AD, using NGF brain-deprived mice (AD11 mice), or multiple-transgenic models, co-expressing mutated forms of APP and presenilin 1 (APPxPS1) or comprising five familial Alzheimer’s disease mutations (5xFAD). The gene discussed is APP; the disease is Alzheimer disease.